● On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
● The company shows low valuation levels, with an enterprise value at 0.19 times its sales.
● The company appears to be poorly valued given its net asset value.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● The company's earnings growth outlook lacks momentum and is a weakness.
● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
● Low profitability weakens the company.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.